CVE-2017-18223
CVE-2017-18223 is a high-severity vulnerability in Bmc Remedy Action Request System with a CVSS 3.x base score of 8.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-287.
Key facts
- Severity: High (CVSS 3.x base score 8.1)
- CVSS v2: 6.8
- EPSS exploit prediction: 1% (58th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-287
- Affected product: Bmc Remedy Action Request System
- Published:
- Last modified:
Description
BMC Remedy AR System before 9.1 SP3, when Remedy AR Authentication is enabled, allows attackers to obtain administrative access.
Frequently asked questions
- What is CVE-2017-18223?
- BMC Remedy AR System before 9.1 SP3, when Remedy AR Authentication is enabled, allows attackers to obtain administrative access.
- How severe is CVE-2017-18223?
- CVE-2017-18223 has a CVSS 3.x base score of 8.1, rated high severity. It is exploitable over network with high attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
- Is CVE-2017-18223 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (58th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2017-18223?
- CVE-2017-18223 affects Bmc Remedy Action Request System. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2017-18223?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
- When was CVE-2017-18223 published?
- CVE-2017-18223 was published on 2018-03-10 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:a:bmc:remedy_action_request_system:*:*:*:*:*:*:*:*
More vulnerabilities in Bmc Remedy Action Request System
- CVE-2018-18862 — High (CVSS 8.8): BMC Remedy Mid-Tier 7.1.00 and 9.1.02.003 for BMC Remedy AR System has Incorrect Access Control in ITAM forms, as…
- CVE-2016-2349 — High (CVSS 7.5): Remedy AR System Server in BMC Remedy 8.1 SP 2, 9.0, 9.0 SP 1, and 9.1 allows attackers to reset arbitrary passwords…
- CVE-2015-9257 — Medium (CVSS 6.1): BMC Remedy Action Request (AR) System 9.0 before 9.0.00 Service Pack 2 hot fix 1 has persistent XSS.
- CVE-2017-18228 — Medium (CVSS 5.4): Remedy Mid Tier in BMC Remedy AR System 9.1 allows XSS via the ATTKey parameter in an arsys/servlet/AttachServlet…
- CVE-2007-0310 — Medium (CVSS 5.0): BMC Remedy Action Request System 5.01.02 Patch 1267 generates different error messages for failed login attempts with a…
All CVEs affecting Bmc Remedy Action Request System →
Other CWE-287 (Improper Authentication) vulnerabilities
- CVE-2026-45480 — Critical (CVSS 10.0): Improper authentication in Azure Active Directory allows an unauthorized attacker to elevate privileges over a network.
- CVE-2026-46389 — Critical (CVSS 10.0): UDS Identity Config builds the Keycloak configuration image (realm, plugins, theme, truststore, JARs) consumed by UDS…
- CVE-2026-10611 — Critical (CVSS 10.0): An authentication bypass vulnerability exists in MISP when LDAP mixed authentication is enabled with OTP enforcement.…
- CVE-2026-47280 — Critical (CVSS 10.0): Improper authentication in Azure Resource Manager (ARM) allows an unauthorized attacker to elevate privileges over a…
- CVE-2026-42822 — Critical (CVSS 10.0): Improper authentication in Azure Local Disconnected Operations allows an unauthorized attacker to elevate privileges…
- CVE-2026-20182 — Critical (CVSS 10.0): May 2026: This security advisory provides the details and fix information for a vulnerability that was discovered and…
Browse all CWE-287 (Improper Authentication) vulnerabilities →